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? ??????????????????????GC-MS? gas chromatography− 
mass spectrometry??GC-ECD? GC− electron capture detection??HPLC-UV? high-
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? 3???????????????????????????????
?????????????????????? E-HyCu® ? 2?????
???????????????matrix solid phase dispersion?MSPD????
??????????????????????? 















ELISA ??? Lab-on-a-CD ?????????????? G ??????
?????? 
? ? 6???????????????????????? 
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?2??????????????????????????????????
??????? ELISA?indirect competitive enzyme linked immunosorbent 
assay?ic-ELISA???? 
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2-2.? ??????? 
?????????????????? 
















? PD-10 ???? GE Healthcare??????? 
 
??????????????? 
? Tween 20 ? BIO-RAD ?????????????? TMB Microwell 
Peroxidase Substrate System?TMB????????????????????
IgG??????? Kirkegaard & Perry Laboratories, Inc.??????????
?? DS-Pharma Biomedica???????????????????????
????????96 ???????????????? Corning Inc.???
???????????????????????? Bio Wascher-50????
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??????????????? 
? ????????Balb/c????7?????SPF??Charles River Laboratories







???????????PEG?1500 ? Roche Applied Science???????









??????????????CCD1, CCD2, CCD3, CCD4?????????
????????? CCD1?CCD2 ???????????????????
??????????????????? CCD2 ?????????????
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??????????? 59 ????????? 30?35 ??????????
????????????????? 20?1???BSA 15 mg (0.227 µmol)??
?????????? 4.54µmol???????????50% (v/v) DMSO-? 1.0mL
? BSA???30 mg/mL, 100 mM???????pH8.0??500 µL??????
















































































???????????????????????? 3???10?1, 8?1, 5?
1????OVA 10mg (0.222 µmol)???????????????? 2.22 µmol
?10????1.78 µmol?8????1.11 µmol?5??????????????








BSA 15mg (0.227 µmol)?????????????DrnA-OSu 2.25 mg?4.54 
µmol?, DrnB-OSu 2.57 mg?4.54 µmol?, DrnC-OSu 2.20 mg?4.54 µmol????
?????????50%(v/v) DMSO-? 1.0 mL? BSA???30 mg/mL, 100 mM
???????pH8.0??500 µL???????????????? DMSO?
? 500 µL??????????????????????? 2.0mL? PBS?
?????????????PD-10??????PBS?????3.5 mL?? 5.0 
mL?????DMSO?????????????????????????
??????????????DrnA-BSA, DrnB-BSA, DrnC-BSA???????
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OVA????????10?1???? 
OVA 10mg (0.222 µmol)?????????????DrnA-OSu 1.11 mg?2.22 
µmol?, DrnB-OSu 1.26 mg?2.22 µmol?, DrnC-OSu 1.07 mg?2.22 µmol????
?????????50% (v/v) DMSO?? 1.0 mL? OVA???20 mg/mL, 100 mM
???????pH8.0??500 µL???????????????? DMSO?
?(4.44 µmol/mL) 500 µL ???????????????????????
2.0mL? PBS??????????????PD-10??????PBS?????
3.5 mL?? 5.0 mL????? DMSO??????????????????
?????????????????????DrnA (10:1)-OVA, DrnB (10:1)-
OVA, DrnC (10:1)-OVA????????? 7mg OVA??????? 
 
OVA????????8?1???? 
OVA 10mg (0.222 µmol)?????????????DrnA-OSu 0.88 mg?1.78 
µmol?, DrnB-OSu 1.01 mg?1.78 µmol?, DrnC-OSu 0.86 mg?1.78 µmol????
?????????50% (v/v) DMSO-? 1.0 mL? OVA???20 mg/mL, 100 mM
???????pH8.0??500 µL???????????????? DMSO?
?(3.56 µmol/mL) 500 µL??????????????????????? 2.0 
mL ? PBS ??????????????PD-10??????PBS ?????
3.5 mL?? 5.0 mL????? DMSO??????????????????
?????????????????????DrnA (8:1)-OVA, DrnB (8:1)-OVA, 
DrnC (8:1)-OVA????????? 7mg OVA??????? 
 
OVA????????5?1???? 
OVA 10mg (0.222 µmol)?????????????DrnA-OSu 0.55 mg?1.11 
µmol?, DrnB-OSu 0.63 mg?1.11 µmol?, DrnC-OSu 0.54 mg?1.11 µmol????
?????????50% (v/v) DMSO-? 1.0 mL? OVA???20 mg/mL, 100 mM
???????pH8.0??500 µL???????????????? DMSO?
?(2.22 µmol/mL) 500 µL??????????????????????? 2.0 
mL ? PBS ??????????????PD-10??????PBS ?????
3.5 mL?? 5.0 mL????? DMSO??????????????????
?????????????????????DrnA (5:1)-OVA, DrnB (5:1)-OVA, 
DrnC (5:1)-OVA????????? 7 mgOVA??????? 
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2-2-2.  ?????? 
? 1?????? Balb/c????7?????SPF?? 1? 5????????
??? 3???????DrnA-BSA, DrnB-BSA, DrnC-BSA?????????
??????????? Ribi??????????????????????
????? 100 µg/body?2???? 50 µg/body? 2????????????




? ???????????Phosphate buffered saline? PBS??? 0.1?0.5 µg/mL
??????????OVA ????????DrnA-OVA, DrnB-OVA, DrnC-
OVA??????OVA????5:1, 8:1, 10:1??100 µL? 96??????
??????????????????????1???????Tween 20
?? PBS? 3????????????? 250 µL???????2???
??????????????????????3???????????
? 15?????????????????20 µL? 50%?????????
?????? 1% BSA??????????????? 2?20 µg/mL? 80 
µL?????????????????????????????????
1 ????????Tween 20 ?? PBS ????????????????
??3???????????????? 3000?????????????
?????? IgG???????100 µL???????1????????
Tween 20?? PBS??????3??????????TMB?? 100?L?




? PBS?? 0.1?0.5 µg/mL??????????OVA????????DrnA-
OVA, DrnB-OVA, DrnC-OVA??????OVA????5:1, 8:1, 10:1??100 
µL? 96????????????????????????????1?
??????Tween 20?? PBS? 3????????????? 250?L?
??????2?????????????????????????3??
?????20 µL? 50%????????B0??????100?1000 ng/mL?
  17 
??????????????????HEPX???????? 50%???
???????B?????????? 1% BSA?????????????
?? 10 µg/mL? 80?L???????1????????Tween 20?? PBS
??????????????????3???????????????
? 3000??????????????????? IgG???????100 µL
???????1????????Tween 20?? PBS??????3???




2-2-3.  ?????????? 


























?????,??????????????????? 102 cells/mL?101 cells/mL












???? Protein G Sepharose 4 Fast Flow?????????????????
???????????????????????????????????









04, DrB-03, DrC-02??????10 % (v/v)?????????????????
???? ic-ELISA ????? 4 ????????????????????
??????????????????HEPX??????????????
40?? 








2-3.  ??????? 
2-3-1.? ????? NMR?? 





yl)acetic acid (DrnA).  
1H NMR (500 MHz, DMSO-d6): 𝛿𝛿 12.30 (br, 1H), 3.37 (dd, J = 15.0, 9.0 Hz, 1H), 
3.00 (dd, J = 9.0, 6.0 Hz, 1H), 2.42 (dd, J = 15.5, 5.5 Hz, 1H), 2.28 (dd, 15.8, 8.8 Hz, 
1H), 2.08 (m, 1H), 1.94 (m, 1H), 1.72 (m, 1H), 1.41 (m, 1H), 1.31 (m, 1H)  
 
3-(2-(4,5,6,7,8,8-Hexachloro-2,3,3a,4,7,7a-hexahydro-1H-4,7-methanoinden-1-
yl)acet-amido)propanoic acid (DrnB).  
1H NMR (500 MHz, DMSO-d6): 𝛿𝛿 12.20 (br, 1H), 7.99 (t, J =5.5 Hz, 1H), 3.38-3.28 
(m, 1H), 3.21 (m, 2H), 3.02 (dd, J = 9.5, 5.0 Hz, 1H), 2.35 (t, 2H), 2.21 (dd, J = 12.3, 
5.0 Hz, 1H), 2.16-2.06 (m, 2H), 1.90 (m, 1H), 1.61 (m, 1H), 1.40-1.30 (m, 2H) 
 
4-(1,4,5,6,7,7-Hexachlorobicyclo[2.2.1]hept-5-en-2-yl)butanoic acid (DrnC). 
 1H NMR (500 MHz, DMSO-d6): 𝛿𝛿 12.10 (br, 1H), 2.76 (m, 1H), 2.65 (dd, J =12.0, 
8.5 Hz, 1H), 2.21 (t, J = 6.8 Hz, 2H), 1.94 (dd, J = 12.5, 4.0 Hz, 1H), 1.65-1.55 (m, 
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?BIO-RAD  Cat. No.172-2055?????????????????? H ??
IgG1?L???????? 




































   
 
 






















??????? 41)??????????????? 50 % (v/v)?????−??











? 9.? ic-ELISA???????????? 












0 10 20 30 40 50
Methanol ( %(v/v) )
OD450













? 10-a.? DrA-04?????? ic-ELISA???? 







???? ??? ? ?? ??? ????
B/B0
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? 10-b.? DrB-03?????? ic-ELISA???? 




? 10-c.? DrC-02?????? ic-ELISA???? 








???? ??? ? ?? ??? ????
B/B0










???? ??? ? ?? ??? ????
B/B0












? 1.? ??????? ic-ELISA????? 
?????
?ng/mL? 
DrA-04?? DrB-03?? DrC-02?? 
?????? 0.40 8.58 1.40 
?????? 6.63 0.40 1.86 








??????%?? 100??IC50????????? IC50?????????? 
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? 2.? ??????????????????????????? 
??????? 
?IC50 ? 50%??????????? 
?????????? 100??IC50????????? IC50?????????? 
?Pr?????????? 200 ng/mL?40 ng/mL/assay??????????????
30%??????????????????? 
  
�������� DrA-04�� DrB-03�� DrC-02��
������ 100 41 116
������ 15 100 99
�������-�����-��HEPX� 21 20 100
���������������-� 100 7 200
����� 9 0.8 30
����� 104 2 83
���������� 11 0.6 Pr
���������� 40 2 60
�������������� 41 Pr Pr
-������� 18 Pr Pr
���������� 5 Pr Pr
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? 6???? 1???????????????????? A?F ?????
???????????????? 40 ng/mL (8 ng/mL/assay)???? 
??????????????? DrA-04????????????????
?? DrB-03?????????????????????HEPX??????












?????? ?????? ?????? HEPX
???A 2 1 1
???B 1 1 1
???C 0.4 1 1
???D 1 0.1 1.9
???E 1 0.2 1.8
???F 1 0.4 1.6
  28 
? 11? 6??????????????????? HEPX????????
??????????????????????????? A, B, C?? 4??, 
3?????????????DrA-04, DrB-03, DrC-02?? ic-ELISA?????
???????????????????????????? 4 ??????
???????????????DrA-04?????????????????
??????????????? A???? B???? C??????????
????????????? IC50, ??? A?2.95 ng/mL???? B?5.16 ng/mL?
??? C?7.03 ng/mL??ic-ELISA????????????????????
???????????????DrB-03??? ??? A?C ? IC50? 7.70?9.79 
ng/mL??????DrC-02??? ??? A?C ? IC50? 9.41?11.3 ng/mL????
??? A, B, C ????????????????????????? ???
??? ic-ELISA????????????????????????????
????????????????????????? 1?2????????
?? HEPX???????????? D, E, F?? 5??, 3?????????
????DrA-04, DrB-03, DrC-02????? ic-ELISA????????????
????? 12????????????? A, B, C????????? 4??
???????????????????DrA-04 ???  ??? D?F ?
IC50? 4.00?4.50 ng/mL??DrB-03??? ??? D?F ? IC50? 13.6?17.0 ng/mL??
DrC-02??? ??? D?F ? IC50? 11.1?12.2 ng/mL???????????
???????????????????????? HEPX ????????
?????????????? 


















 (a) DrA-04?? (b) DrB-03?? (c)DrC-02?? 
 
? 11.? ?????? A?C????????????????? 
 
 
? 4.?  ???????A?C????????????????????? 
???????? 
??????? HEPX??????????????????????????? 







???? ??? ? ?? ??? ????
B/B0







???? ??? ? ?? ??? ????
B/B0







???? ??? ? ?? ??? ????
B/B0
Chlorinated cyclodienes (ng/mL) 
変化なし 変化なしディルドリンに対して濃度依存的に変化
●：混合液A ●：混合液B ●：混合液C
?????? ?????? ?????? HEPX
???A 2 1 1
???B 1 1 1
???C 0.4 1 1
  30 
 
 (a) DrA-04?? (b) DrB-03?? (c)DrC-02?? 
  

















???? ??? ? ?? ??? ????
B/B0







???? ??? ? ?? ??? ????
B/B0







???? ??? ? ?? ??? ????
B/B0
Chlorinated cyclodienes (ng/mL) 
変化なし 変化なし 変化なし
●：混合液A ●：混合液B ●：混合液C
?????? ?????? ?????? HEPX
???D 1 0.1 1.9
???E 1 0.2 1.8
???F 1 0.4 1.6








X : HEPX??? (DrA-04) ? Y : HEPX??? (DrC-02)  








 X = D (ng/mL) ´ 4.76 + Hs (ng/mL) ? (2)      
  
DrC-02??????????????????? 
 ??????HEPX / Dieldrin? = 100 /116 = 0.86 ? (3) 
  
DrC-02?????? ic-ELISA???????????HEPX??? (ng/mL) 
?Y?????? 
 Y = D (ng/mL) ´ 0.86 + Hs (ng/mL) ? (4) 
  
?(2) ???? (4) ??  
 D (ng/mL) = (X? Y) / (4.76? 0.86) = ( X? Y ) / 3.90 ? (5) 
  
? (4) ??????? 
 Hs (ng/mL) = Y? D ´ 0.86 ? (6) 
  
  32 
2-3-3-2.? ???????????????????????????????
????????????????????  
DrA-04?????? ic-ELISA ? DrC-02?????? ic-ELISA?????






???? 88.1?125 %?????????????????????? 









? 6.? ??????? 2??????DrA-04, DrC-02????? ic-ELISA? 
???????????????????????????????? 




????? ?????? ??????? ?????? ??????? ?????? ???????
???A 4.36 4.25 4.00 4.00 109 106
???B 2.39 5.95 2.67 5.34 89.5 112
???C 1.17 6.99 1.33 6.66 88.1 105
???D 3.03 5.39 2.67 5.33 114 102
???E 3.34 5.13 2.67 5.33 125 96.2
???F 3.03 5.40 2.67 5.33 114 101









????? 7 ?????DrA-04 ??? ic-ELISA?????????????
?????? 5.0?5.9 %?????? 2.6?3.9 %????DrC-02??? ic-ELISA




???DrA-04?????????HEPX?DrC-02???? 4 ng/mL/assay? 20 
ng/mL/assay ???????????? DrA-04??? ic-ELISA ? 88.8− 108%?
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? 7.? ic-ELISA??????????? 
?nd????????? 
?????????? n=3,?  










8.0 ng/mL, CV (%) 5.9 1.5
40.0 ng/mL, CV (%) 5.0 1.3
????
8.0 ng/mL, CV (%) 3.9 6.2





????? 4 ng/mL/assay ??
??? (%) 97.5 85.8
????? 20 ng/mL/assay??




????? 4 ng/mL/assay ??
??? (%) 108 108
????? 20 ng/mL/assay??
??? (%) 100 129








POPs ??????????????????????? 1972 ??????
??????????????????????????????????HEPX?
???????????????????????????????????
????0.03 mg Kg-1??????????????????????? 17)?  
??????????????????????????????????















???? E-HyCu® 49)??????????????matrix solid phase dispersion?
MSPD?? 50)????????  
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3-2.? ??????? 
?????????????????? 














? ???????? Tween 20 ? BIO-RAD ??????????OVA??
SIGMA-ALDRICH???????????????HRP, maleimide activated?
? ThermoFischer Scientific??????ic-ELISA?????? TMB Microwell 
Peroxidase Substrate System?TMB?? Kirkegaard & Perry Laboratories, Inc.??
?????96???????????????? Corning Inc.???????
????????? 2?????? DrC-02??? HRP?????????
???????? 96 ???????? Greiner Bio-One ???ic-ELISA ??
?? 96???????????????? Corning Inc.??????????
????????????????? Bio Wascher-50???????????
?????????????? Chro Mate?R?Awareness Technology Inc.???
???? 
 
3-2-1.? ????????????? ic-ELISA???? 
??????? DrnC?OVA?10?1??0.08ng/mL, 100 µL?????????
???????? 96?????????????????25% (v/v) DMSO−?
????????? 20 µL?????????80 µL? HRP?? DrC-02??
  37 
?0.04 ng/mL, 100 µL????????1?????????????????
??0.05% Tween 20 ?????????????????????100 µL ?
TMB ???????? 10 ????????100 µL ? 1M ????????
















3-2-3-1.?  ???????????????????? 
? ?????????????150 mg??????????50% (v/v)???
??−?????? HEPX????10 ng/mL?5 mL???? vortex?? 30?
???????????3500 rpm, 1??????????????50% (v/v)
?????−? 2 mL?????????????????????????
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?????????0.25 mL? DMSO????????? 0.75 mL????




? 5 mL??? 1 g??????? vortex?? 30????????????3500 
rpm, 1?????????????50% (v/v)?????−? 5 mL??? 10?




????????????????????50% (v/v)?????−? 2 mL?
??????????????????????????????????




DMSO????????? 0.75 mL????? 25% (v/v) DMSO?????
??ic-ELISA????????? 
 
3-2-4.? ???????????E-HyCu®?????? MSPD ???????
????????? 
? ??????????????????????150 mg????????
?? 5 mL??? 1 g ??????? vortex ?? 30 ???????????
?3500 rpm, 1???????????????50% (v/v)?????−? 5 mL?
?? 10?? vortex??????????????????????????
50% (v/v)?????−? 2 mL??????????????????????
??????????????????????6 mL???????????
????????????????? 50% (v/v)?????−? 2 mL????
??????????????????????????????? 50% (v/v)
?????−? 2 mL????????????????????????? E-
HyCu®???250 mg??????????????????????????
  39 




????? 0.125 mL? DMSO????????. ???? 0.375 mL????
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3-3.? ??????? 





ic-ELISA??????. 14????HEPX?????????? 0.34 ng/mL?
?????? 1.08 ng/mL?????? 40)?????????2.78?3.09 %??
????1.49?3.70 %? CV?????? ic-ELISA????????????
?????????? 8?? 
? ic-ELISA?????? 100 µL? 20 µL???????????????
???????? ic-ELISA??5?????????????????ic-ELISA
???????????????? HEPX???ic-ELISA?????????
1.08 ng/mL? 5?????? 5.4 ng/mL??????? 
??????????????????????????????,???
? 1 g? 5 ng?0.005 mg/Kg??????????? 51)???????????
????????????????? ic-ELISA??????????????
??? 1g??????? 2????????????????? 
  
  42 
????????-?????????????DrnC-OVA, 0.08 µg/mL (100 µL) 
?????????HRP??? DrC-02??, 0.04 µg/mL (80 µL) 
??????5% DMSO -PBS 
??????n=5 
? 14. ? ic-ELISA??? HEPX???? 
 
 
? 8.? HEPX??? ic-ELISA???????? 
???????????????????????? n=3.?  







0.01 0.1 1 10 100 1000
B/B0
heptachlor-cis -epoxide (HEPX)  (ng/mL)



























? 16.? ic-ELISA?????? 
  
DrnC-OVA固相化マイクロプレート
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3-3-2.?  ???????????????????? 
??????????????? HEPX ????????????????
??????? 50% (v/v)?????−?? 10 ng/mL ??????????
HEPX????????3-2-3-1?????????????????????
?????????ic-ELISA?????? 9???????????????
















? 9.? ???????????? HEPX?????????? 
??????? HEPX?????10 ng/mL/assay 
?ic-ELISA??????n=3 
 
Test # 1 Test # 2 Test # 3 Test # 4
iC-ELISA???
(ng/mL/assay) 10.8 10.8 11.3 10.8
??? (%) 108 108 113 108
CV (%) 5.43 2.13 3.55 3.87
  45 
3-3-3.?  ????????????????MSPD???????? 
????????????????MSPD???????????????
???????HEPX???????????????? 10????????
?????????? ic-ELISA??????????? 6???????? 4
??????? A?B?E?F??????????????????????
?????4????????? 2 ng/mL??? 10 ng/mL?????????







????????????????????? A ??? E ????????
???????????????????????????????????
???????? ic-ELISA ?????????? A?C ??? F ?????
?? 50.0%?71.2%?67.6%?????????????????????? ic-
ELISA????????????????????????????????
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? 10.? ????????????????????????? 
????????? 
?ic-ELISA??????n=3,?  
?? (ng/mL/assay)???? (ng/mL/assay) ? ???????? (ng/mL/assay),?   
? nd????????? 
???????????????????? MSPD?????????????GC-MS














3.67 3.07 2.76 2.52 3.69 4.04
184 % 154 % 138 % 126 % 185 % 202%
Δ (ng/mL/assay)
1.82 1.95 2.76 2.52 2.17 1.96





11.6 10.2 11.2 10.3 11.6 13.0
116 % 102 % 112 % 103 % 116 % 130 %
Δ (ng/mL/assay) 
9.75 9.08 11.2 10.3 10.1 10.9










33.8 9.67 10.1 11.6 21.9 8.28
335 % 97.0 % 101 % 116 % 219 % 82.8 %
Δ (ng/mL/assay) 
5.00 9.67 7.12 10.2 9.10 6.76
50.0 % 96.7 % 71.2 % 102 % 91.0 % 67.6 %
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Test # 1 Test # 2
ic-ELISA???
(ng/mL/assay) 10.5 9.80
??? (%) 105 98.0
CV (%) 2.61 3.38
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 ?????????????? ???????????? 
  E-HyCu®?? 
 
 



















0 10 20 30 40 50





















































Sakai???? 41)??????? 8 g??????? 40 mL???? 1?5??






????????????? 0.375 mL????? 25% (v/v) DMSO?????
??????? ic-ELISA????????? 
 
50% (v/v) ?????−???? 24???????????????????








  51 
 
? 12.? ????? GC−MS???? 
  
?????HP6890-5975N, Agilent Technologies.  
??????250?????????????????? 1 mL min-1?. 
???????????280?????????250?? 
??????150?????ENV-8?0.25 mm?30 m, 0.25 µm?. 
?????120??10?min-1 ?180??5?min-1?300??10 min.? 





60 ?????????? ic-ELISA ? GC−MS ????????????
GC−MS ???????????????? 34 ??? ic-ELISA ??????
????????????ic-ELISA???????????????????
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?5??Lab-on-a-CD?????????? 
5-1.? ???? 


























????????? compact disc?????? 3??????????? 3?
? Lab-on-a-CD ????????????????? 64)?65)?3 ?? Lab-on-a-
CD ? 3 ???????????????????3 ???????????
???????????????????????????????????
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5-2.? Lab-on-a-CD??? 
???????????????????????????? 3?? Lab-on-
a-CD??????3?? Lab-on-a-CD ? LIGA?Lithographie, Galvanoformung, 
Abformung?process??????????????? CD? µTAS?????
???? 3 ????????????????????????????






















































































? 20.? ??????????????  
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 (a) 1??????? (b)??? 1?????? (c)???? 2??? 

















































? ?：1次抗体 ：抗原（分析対象物） ：酵素標識2次抗体










P(MMA/CEMA)???????? polyethyleneimine (PEI)?30 w t %?????
??????????????? PEI ??????????? 71????




? 22.?  P(MMA/CEMA)?????????????? 
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??????????? 
???? X??????(XPS: X-ray Photoelectron Spectroscopy)??????
???X ??????????????????????????????
?????????????MgK??????? 
???????? XPS ?????????????????? 24-(a)??
????????? C1s ???????962.4 eV????????????
?????? P(MMA/CEMA)???PEI ???? P(MMA/CEMA)?????
???? PMMA ??????????? C1s ??????? O1s ????
??????????????PEI?????? P(MMA/CEMA)???? N1s
???????????????PEI ?????????????????
??????? 24-(b)??Cl2p ???????C1s ???????????
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? 24-(a).?  XPS????????????? 
 
 





















































































No.3: P(MMA/CEMA), PEI (M.W., 10000) 1hr.処理
No.4: P(MMA/CEMA), PEI (M.W., 10000) 12hr.処理
No.5: P(MMA/CEMA), PEI (M.W., 10000) 30hr.処理
No.6: P(MMA/CEMA), PEI (M.W., 1800)  1hr.処理
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(a) P(MMA/CEMA)???? (b)????????  




(a) PMMA  (b)P(MMA/CEMA) 
 




  63 


















































































?????? P(MMA/CEMA)?? 1 ????????????? biotin N-
hydroxy-succinimide ester?100?g/ml????????????????????
?????????????????????Horseradish peroxidase : HRP??
???????????100?g/ml????????????????????
????????????????????????????? 0.05% tween 
20?? PBS?????????????????????? 





? 28 ???????PEI ????????????? P(MMA/CEMA) ??
????? HRP ????????HRP ?????????????????
????????????????????? P(MMA/CEMA)?? HRP ??
????????PEI??????? biotin N-hydroxysuccinimide ester????
??????????????????????????????????
???biotin N-hydroxy- succinimide ester?????????????????










No. 1? P(MMA/CEMA), PEI ??? biotin N-hydroxysuccinimide ester?? 
No. 2? P(MMA/CEMA), PEI ???? biotin N-hydroxysuccinimide ester ?? 
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5-4.? Lab-on-a-CD?????????????? G??????? ELISA?
?? 
5-4-1.? ???? 
????? P(MMA/CEMA)??? 1???????????????? 3?
? Lab-on-a-CD????????????????????????????
?? G???????????????????????PEI???????
????? P(MMA/CEMA)?????? 3 ???????????PDMS ??
?????3????????????????? 




?10?l??????????1 ??????????1 %  ????????
??bovine serum albumin ?BSA????10?l??????????????
?????????????????????????????????1 ?
???????? Lab-on-a-CD ?????????????? G ?????
?? ELISA????????????????????????? G?3?l??
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???????????????????????????????????
??? 1 ????????????? Lab-on-a-CD ?? 3 fg/assay?3?10-
12g/assay????????????? G?????????????????
???????????????????????????????????














????? ???? ??? ? ?? ??? ????
OD450
Immunoglobulin G, mouse (ng/assay) 
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?6???? 


























?????????????????????? E-HyCu® ? 2?????












?E-HyCu® ? 2?????????? MSPD?????????????
?????????????ic-ELISA ????????????????
??????????????????? 



















? 5?? Lab-on-a-CD?????????????????? 
Lab-on-a-CD ???????????????????????????
??????????????????????????????????
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